Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 6, 1996, Pages 689-700

  Lynn, Freyja ^a   Reed, George F ^b   Meade, Bruce D ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; PERTUSSIS TOXIN;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BORDETELLA PERTUSSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; STANDARDIZATION;

EID: 0029859974     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.6.689-700.1996     Document Type: Article

References (22)

1. Ad Hoc Group for the Study of Pertussis Vaccines. 1988. Placebo-controlled trial of two acellular vaccines in Sweden - protective efficacy and adverse effects. Lancet i:955-960.
2. Bishop, Y. M. M., S. E. Fienberg, and P. W. Holland. 1975. Discrete multivariate analysis. MIT Press, Cambridge, Mass.
3. Carlone, G. M., C. E. Frasch, G. R. Siber, S. Quataert, L. L. Gheesling, S. H. Turner, B. D. Plikaytis, L. O. Helsel, W. E. DeWitt, W. F. Bibb, B. Swaminathan, G. Arakere, C. Thompson, D. Phipps, D. Madore, and C. V. Broome. 1992. Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J. Clin. Microbiol. 30:154-159.
4. Chambers, J. M., and W. S. Cleveland. 1983. Graphical methods for data analysis. Wadsworth International Group, Belmont, Calif., and Duxbury Press, Boston.
5. Conover, W. J. 1971. Practical nonparametric statistics. John Wiley & Sons, Inc., New York.
6. Draper, N., and H. Smith. 1966. Applied regression analysis. John Wiley & Sons, Inc., New York.
7. Edwards, K. M., B. D. Meade, M. D. Decker, G. F. Reed, M. B. Rennels, M. C. Steinhoff, E. L. Anderson, J. A. Englund, M. E. Pichichero, M. A. Deloria, and A. Deforest. 1995. Comparison of 13 acellular pertussis vac-cines: overview and serologic response. Pediatrics 96(Suppl.):548-557.
8. Greco, D., S. Salmaso, P. Mastrantonio, M. Giuliano, A. E. Tozzi, A. Anemona, M. L. Ciofi degli Atti, A. Giammanco, P. Panei, W. C. Blackwelder, D. L. Klein, and S. G. Wassilak. 1996. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N. Engl. J. Med. 334:341-348.
9. Gustafsson, L., H. O. Hallander, P. Olin, E. Reizenstein, and J. Storsaeter. 1996. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334:349-355.
10. Hallander, H. O., J. Storsaeter, and R. Möllby. 1991. Evaluation of serology and nasopharyngeal cultures for diasnosis of pertussis in a vaccine efficacy trial. J. Infect. Dis. 163:1046-1054.
11. Madore, D. V., P. Anderson, B. D. Baxter, G. M. Carlone, K. E. Edwards, R. G. Hamilton, P. Holder, H. Käyhty, D. C. Phipps, C. C. A. Peeters, R. Schneerson, G. R. Siber, J. I. Ward, and C. E. Frasch. 1996. Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 3:84-88.
12. Manclark, C. R., B. D. Meade, and D. G. Burstyn. 1986. Serologic response to Bordetella pertussis, p. 388-394. In N. R. Rose, H. Friedman, and J. L. Fahey (ed.), Manual of clinical laboratory immunology, 3rd ed. American Society for Microbiology, Washington, D.C.
13. Meade, B. D., A. Deforest, K. M. Edwards, T. A. Romani, F. Lynn, C. H. O'Brien, C. B. Swartz, G. F. Reed, and M. A. Deloria. 1995. Description and evaluation of serologic assays employed in a multicenter trial of acellular pertussis vaccines. Pediatrics 96(Suppl.):570-575.
14. Meade, B. D., H. O. Hallander, T. A. Romani, L. Mardin, C. B. Swartz, M. Ljungman, B. Reizenstein, R. Möllby, W. C. Blackwelder, and C. R. Mandark. 1990. A standard enzyme-linked immunosorbent assay procedure for quantitation of immunoglobulin G antibodies to pertussis toxin and filamen-tous hemagglutinin. In C. R. Manclark (ed.), Abstracts of the Sixth International Symposium on Pertussis DHHS Publication (FDA) 90-1162. U.S. Public Health Service, Bethesda, Md.
15. Mink, C. M., J. D. Cherry, P. Christenson, K. Lewis, E. Pineda, D. Shlian, J. A. Dawson, and D. A. Blumberg. 1992. A search for Bordetella pertussis infection in university students. Clin. Infect. Dis. 14:464-471.
16. Plikaytis, B. D., P. F. Holder, L. B. Pais, S. E. Maslanka, L. L. Gheesling, and G. M. Carlone. 1994. Determination of parallelism and nonparallelism in bioassay dilution curves. J. Clin. Microbiol. 32:2441-2447.
17. Reizenstein, E., H. O. Hallander, W. C. Blackwelder, I. Kühn, M. Ljungman, and R. Möllby. 1995. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J. Immunol. Methods 183:279-290.
18. Rosenthal, S., P. Strebel, P. Cassiday, G. Sanden, K. Brusuelas, and M. Wharton. 1995. Pertussis infection among adults during the 1993 outbreak in Chicago. J. Infect. Dis. 171:1650-1652.
19. Schmitt, H. J., C. H. von Konig, A. Neiss, H. Bogaerts, H. L. Bock, S.-W. H., M. Gahr, R. Schult, J. U. Folkens, W. Rauh, and R. Clemens. 1996. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 275:37-41.
20. Shah, V. P., K. K. Midha, S. Dighe, I. J. McGilveray, J. P. Skelly, A. Yacob, T. Layloff, C. T. Viswanathan, C. E. Cook, R. D. McDowall, K. A. Pittman, and S. Spector. 1992. Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies. J. Pharm. Sci. 81:309-312.
21. Snedecor, G. W., and W. G. Cochran. 1980. Statistical methods, 3rd ed. The Iowa State University Press, Ames.
22. Trollfors, B., J. Taranger, T. Lagergard, L. Lind, V. Sundh, G. Zackrisson, C. U. Lowe, W. Blackwelder, and J. B. Robbins. 1995. A placebo-controlled trial of a pertussis-toxoid vaccine. N. Engl. J. Med. 333:1045-1050.